119-hres305

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 305 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
H. RES. 305

 Expressing support for the designation of the fourth Wednesday of 
 February as ``Hypertrophic Cardiomyopathy Awareness Day''.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 April 8, 2025

 Mr. LaHood submitted the following resolution; which was referred to 
 the Committee on Energy and Commerce

_______________________________________________________________________

 RESOLUTION

 Expressing support for the designation of the fourth Wednesday of 
 February as ``Hypertrophic Cardiomyopathy Awareness Day''.

Whereas hypertrophic cardiomyopathy (``HCM'') is a chronic cardiac disease 
 involving thickening of the heart muscle and can potentially lead to 
 debilitating symptoms and serious complications including heart failure, 
 atrial fibrillation, stroke, and in rare cases sudden cardiac death;
Whereas HCM is the most common inheritable heart disease and can affect anyone 
 regardless of age, gender, or ethnicity with a reported prevalence 
 ranging from 1 in 200 to 1 in 500 in the general population;
Whereas an estimated 700,000 to 1,650,000 people in the United States have HCM, 
 yet 85 percent of them may remain undiagnosed;
Whereas HCM shares symptoms with other common cardiovascular and pulmonary 
 diseases, such as shortness of breath, chest pain, fatigue, 
 palpitations, and fainting, making it difficult to distinguish HCM from 
 these other diseases;
Whereas, when untreated, all-cause mortality risk is 3 to 4 times higher in 
 patients with HCM than that of the general population;
Whereas knowing one's medical history and any signs and symptoms of HCM is an 
 important first step in receiving an accurate diagnosis of HCM;
Whereas a health care provider must conduct thorough screening with cardiac 
 health questions to help identify a risk of cardiac disorders, both 
 genetic and congenital;
Whereas a health care provider may conduct several tests, including an 
 echocardiogram, a cardiac MRI, or genetic testing to confirm a family 
 history of HCM, and must examine the heart to diagnose HCM;
Whereas, following a diagnosis of HCM, it is important for patients to work with 
 their health care provider to learn more about their disease and 
 understand different management options, including prescription 
 medicines and surgical treatment options that may help; and
Whereas ``Hypertrophic Cardiomyopathy Awareness Day'' is expected to be observed 
 in the United States for years to come, providing hope and information 
 for patients, caregivers, and families around the country: Now, 
 therefore, be it
 Resolved, That the House of Representatives--

    (1) supports the designation of ``Hypertrophic 
 Cardiomyopathy Awareness Day'';

    (2) acknowledges the critical importance of hypertrophic 
 cardiomyopathy awareness to improve cardiovascular health; and

    (3) recognizes the need to raise public awareness of the 
 consequences of undiagnosed and untreated hypertrophic 
 cardiomyopathy and urges all Americans to seek appropriate 
 care.
 <all>